Back

ScientiaCME

  • Adenosine
  • Candidiasis, Oral
  • Diarrhea
  • Rare Diseases
  • Severe Combined Immunodeficiency

Early detection, lifetime protection: ADA-SCID identification and management, from cradle to adulthood

In this online, self-learning activity: Adenosine deaminase-deficient severe combined immunodeficiency (ADA-SCID) is a rare genetic disorder caused by mutations in the adenosine deaminase (ADA) gene. ADA-SCID is a specific form of severe combined immunodeficiency that results from ADA deficiency. Mutations in the ADA gene result in an accumulation of deoxyadenosine which leads to the destruction of lymphocytes, affecting the integrity of the immune system. This disease leaves individuals highly susceptible to infection such as pneumonia, chronic diarrhea, and oral thrush, which typically manifests soon after birth. The median age at diagnosis is between 1-3 months of age, although there is variability with some individuals having a later presentation onset. ADA deficiency accounts for approximately 10-15% of all SCID cases with an overall prevalence of 1 in 500,000 live births. It remains a rare disease and requires specialized immunologists, novel gene therapies, and transplant physicians to create a wholistic care plan.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

ABP — Lifelong Learning and Self-AssessmentUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME · seen on scientiacme.org

  • On-demand / recorded video
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Commercial Support
  • Released
    Feb 1, 2025
  • Last day to claim credit
    Feb 2, 2027 4 months left